Advisor Group Holdings, Inc. Novo Cure LTD Transaction History

Advisor Group Holdings, Inc.

$52.6 Billion
Q2 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Novo Cure LTD stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 3,226 shares of NVCR stock, worth $47,293. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,226

Previous 2,808 14.89%

Holding current value

$47,293

Previous $49,000 16.33%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Sep 04, 2025	BUY	$15.37 - $19.4 $6,424 - $8,109	418 Added 14.89%	3,226 $57,000
Q2 2025 Aug 13, 2025	SELL	$15.37 - $19.4 $1,490 - $1,881	-97 Reduced 3.34%	2,808 $49,000
Q1 2025 May 12, 2025	BUY	$17.82 - $30.19 $13,347 - $22,612	749 Added 34.74%	2,905 $51,000
Q4 2024 Jun 06, 2025	SELL	$14.54 - $33.41 $3,024 - $6,949	-208 Reduced 7.16%	2,697 $80,000
Q4 2024 Feb 07, 2025	BUY	$14.54 - $33.41 $1,613 - $3,708	111 Added 5.43%	2,156 $64,000
Q3 2024 Nov 13, 2024	SELL	$15.61 - $23.34 $6,712 - $10,036	-430 Reduced 17.37%	2,045 $31,000
Q2 2024 Aug 13, 2024	SELL	$11.83 - $24.05 $28,072 - $57,070	-2,373 Reduced 48.95%	2,475 $42,000
Q1 2024 May 10, 2024	SELL	$12.42 - $17.29 $14,941 - $20,799	-1,203 Reduced 19.88%	4,848 $75,000
Q4 2023 Feb 12, 2024	SELL	$11.13 - $15.78 $9,360 - $13,270	-841 Reduced 12.2%	6,051 $90,000
Q3 2023 Nov 13, 2023	SELL	$16.15 - $42.35 $10,126 - $26,553	-627 Reduced 8.34%	6,892 $111,000
Q2 2023 Aug 21, 2023	SELL	$40.29 - $82.51 $130,539 - $267,332	-3,240 Reduced 30.11%	7,519 $312,000
Q2 2023 Aug 10, 2023	BUY	$40.29 - $82.51 $116,075 - $237,711	2,881 Added 36.57%	10,759 $446,000
Q1 2023 May 12, 2023	SELL	$56.44 - $118.81 $82,176 - $172,987	-1,456 Reduced 15.6%	7,878 $473,000
Q4 2022 Feb 10, 2023	SELL	$63.98 - $85.37 $59,437 - $79,308	-929 Reduced 9.05%	9,334 $684,000
Q3 2022 Nov 14, 2022	SELL	$67.99 - $89.57 $90,290 - $118,948	-1,328 Reduced 11.46%	10,263 $780,000
Q2 2022 Aug 10, 2022	SELL	$56.6 - $89.9 $1,981 - $3,146	-35 Reduced 0.3%	11,591 $807,000
Q1 2022 May 04, 2022	BUY	$60.15 - $84.52 $162,164 - $227,865	2,696 Added 30.19%	11,626 $938,000
Q3 2021 Nov 05, 2021	SELL	$116.17 - $194.55 $1.16 Million - $1.94 Million	-9,980 Reduced 52.78%	8,930 $1.04 Million
Q2 2021 Aug 02, 2021	BUY	$130.4 - $225.58 $1.25 Million - $2.16 Million	9,597 Added 103.05%	18,910 $4.16 Million
Q1 2021 May 13, 2021	SELL	$124.11 - $190.17 $1.2 Million - $1.84 Million	-9,665 Reduced 50.93%	9,313 $1.23 Million
Q4 2020 Feb 10, 2021	SELL	$112.16 - $174.14 $482,736 - $749,498	-4,304 Reduced 18.49%	18,978 $3.28 Million
Q3 2020 Nov 12, 2020	BUY	$58.05 - $111.31 $775,141 - $1.49 Million	13,353 Added 134.48%	23,282 $2.54 Million
Q2 2020 Aug 14, 2020	SELL	$57.2 - $74.41 $2.58 Million - $3.36 Million	-45,099 Reduced 81.96%	9,929 $590,000
Q1 2020 May 18, 2020	BUY	$57.05 - $95.75 $3.14 Million - $5.27 Million	55,028 New	55,028 $2.33 Million

Others Institutions Holding NVCR

# of Institutions

285

Shares Held

77.5M

Call Options Held

943K

Put Options Held

155K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.54B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Novo Cure LTD Transaction History